Sign Up Today and Learn More About Nammi Therapeutics Stock
Invest in or calculate the value of your shares in Nammi Therapeutics or other pre-IPO companies through EquityZen's platform.
Nammi Therapeutics Stock (NATH)
Nammi Therapeutics is an immunotherapy company that develops nano-enabled chemo-immunotherapy for the treatment of cancer.
About Nammi Therapeutics Stock
Founded
2018
Headquarters
Los Angeles, CA, US
Industries
Software, Artificial Intelligence, Financial Services
Nammi Therapeutics Press Mentions
Stay in the know about the latest news on Nammi Therapeutics
Formulated and/or co-formulated liposome compositions containing tgfb …
patents • May 04, 2025
Formulated and/or co-formulated lipid nanocarriers compositions containing toll …
patents • May 04, 2025
FUSION PROTEIN COMPOSITION(S) COMPRISING MASKED TYPE I INTERFERONS (IFNα AND …
patents • Apr 02, 2025
Formulated and/or Co-Formulated Liposome Compositions Containing PD-1 …
patents • Feb 11, 2025
Fusion protein composition(s) comprising masked type i interferons (ifna and …
patents • Feb 11, 2025
Nammi Therapeutics Management
Leadership team at Nammi Therapeutics
Founder and CEO
David Stover
Join now and verify your accreditation status to gain access to:
- Nammi Therapeutics Current Valuation
- Nammi Therapeutics Stock Price
- Nammi Therapeutics Management
- Available deals in Nammi Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Nammi Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Nammi Therapeutics Revenue and Financials
- Nammi Therapeutics Highlights
- Nammi Therapeutics Business Model
- Nammi Therapeutics Risk Factors
- Nammi Therapeutics Research Report from SACRA Research
Trading Nammi Therapeutics Stock
How to invest in Nammi Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Nammi Therapeutics through EquityZen funds. These investments are made available by existing Nammi Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Nammi Therapeutics stock?
Shareholders can sell their Nammi Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
